Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Ussia, M. Scarabelli, M. Mulé, M. Barbanti, K. Sarkar, V. Cammalleri, S. Immé, P. Aruta, A. Pistritto, Simona Gulino, W. Deste, D. Capodanno, C. Tamburino (2011)
Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation.The American journal of cardiology, 108 12
(2011)
Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy
(Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–2496.)
Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–2496.Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–2496., Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–2496.
M. Leon, N. Piazza, E. Nikolsky, E. Blackstone, D. Cutlip, A. Kappetein, M. Krucoff, M. Mack, R. Mehran, Craig Miller, M. Morel, J. Petersen, J. Popma, J. Takkenberg, A. Vahanian, G. Es, P. Vranckx, J. Webb, S. Windecker, P. Serruys (2011)
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.Journal of the American College of Cardiology, 57 3
(2015)
Cardiol Ther
M. Leon, N. Piazza, E. Nikolsky, E. Blackstone, D. Cutlip, A. Kappetein, M. Krucoff, M. Mack, R. Mehran, Craig Miller, M. Morel, J. Petersen, J. Popma, J. Takkenberg, A. Vahanian, G. Es, P. Vranckx, J. Webb, S. Windecker, P. Serruys (2010)
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium†European Heart Journal, 32
(Zeymer U, Zahn R, Gerckens U, Richard G, Figulla HR, Senges J. Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy. Eur Heart J. 322011:900.)
Zeymer U, Zahn R, Gerckens U, Richard G, Figulla HR, Senges J. Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy. Eur Heart J. 322011:900.Zeymer U, Zahn R, Gerckens U, Richard G, Figulla HR, Senges J. Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy. Eur Heart J. 322011:900., Zeymer U, Zahn R, Gerckens U, Richard G, Figulla HR, Senges J. Antithrombotic therapy after transfemoral aortic valve implantation (TAVI). Potential hazard of triple-therapy. Eur Heart J. 322011:900.
Rick Nishimura, C. Otto, R. Bonow, B. Carabello, J. Erwin, R. Guyton, P. O'Gara, C. Ruiz, N. Skubas, P. Sorajja, T. Sundt, James Thomas (2014)
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation, 129 23
Rick Nishimura, C. Otto, R. Bonow, B. Carabello, J. Erwin, R. Guyton, P. O'Gara, C. Ruiz, N. Skubas, P. Sorajja, T. Sundt, James Thomas (2014)
Correction: 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Journal of the American College of Cardiology (2014) 63 (2438-88))Journal of the American College of Cardiology, 63
David Holmes, Michael Mack, Vice Chair, S. Kaul, A. Agnihotri, Karen Alexander, Steven Bailey, John Calhoon, Blase Carabello, Milind Desai, Fred Edwards, Gary Francis, T. Gardner, A. Kappetein, Jane Linderbaum, C. Mukherjee, D. Mukherjee, Catherine Otto, Carlos Ruiz, Ralph Sacco, Donnette Smith, James Thomas (2012)
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.Journal of the American College of Cardiology, 59 13
(2010)
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgeryN Engl J Med, 363
Rick Nishimura, C. Otto, R. Bonow, B. Carabello, J. Erwin, R. Guyton, P. O'Gara, C. Ruiz, N. Skubas, P. Sorajja, T. Sundt, James Thomas (2014)
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 63 22
B. Carabello (2011)
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryCurrent Cardiology Reports, 13
A. Vahanian, O. Alfieri, F. Andreotti, M. Antunes, G. Barón-Esquivias, H. Baumgartner, M. Borger, T. Carrel, M. Bonis, A. Evangelista, V. Falk, B. Iung, P. Lancellotti, L. Pierard, S. Price, H. Schäfers, G. Schuler, J. Stȩpińska, K. Swedberg, J. Takkenberg, U. Oppell, S. Windecker, J. Zamorano, M. Zembala (2012)
Guidelines on the management of valvular heart disease (version 2012).European heart journal, 33 19
V. Nijenhuis, P. Stella, J. Baan, B. Brueren, P. Jaegere, P. Heijer, S. Hofma, P. Kievit, T. Slagboom, A. Heuvel, F. Kley, L. Garsse, K. Houwelingen, A. Hof, J. Berg (2013)
Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitalsNetherlands Heart Journal, 22
Cardiol Ther (2015) 4:197–201 DOI 10.1007/s40119-015-0050-2 BRIEF REPORT Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience . . . . Jeffrey E. Rossi Andrew Noll Brian Bergmark James M. McCabe . . . . David Nemer David R. Okada Anant Vasudevan Michael Davidson . . . Frederick Welt Andrew Eisenhauer Pinak Shah Robert Giugliano To view enhanced content go to www.cardiologytherapy-open.com Received: August 21, 2015 / Published online: September 23, 2015 The Author(s) 2015. This article is published with open access at Springerlink.com Results: Of a total of 255 patients undergoing ABSTRACT the procedure, 132 (51%) had an indication for Introduction: The aim of this study was to anticoagulation pre-TAVR and 92 (70% of those describe peri-procedural antithrombotic use in with an indication) were on treatment. On patients undergoing transcatheter aortic valve discharge, 106 patients (44% of total surviving replacement (TAVR) at a single academic to discharge, 73% of those surviving with an medical center. indication for anticoagulation) were treated Methods: Retrospective collection of with oral anticoagulation. Of these patients, antiplatelet and anticoagulant use during the 89 (84%) were discharged on aspirin and an oral index hospitalization for all patients anticoagulant without clopidogrel. Only 122 undergoing
Cardiology and Therapy – Springer Journals
Published: Sep 23, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.